GLP-1 Boom Reshapes U.S. Food Costs and Markets
By late 2025, roughly 12% of U.S. adults were using GLP-1 weight-loss medications, a trend that is quietly trimming g...
Explore unique ways to make money from ideas online. Unlock your potential and start boosting your income with creative strategies.
15,650 articlesBy late 2025, roughly 12% of U.S. adults were using GLP-1 weight-loss medications, a trend that is quietly trimming g...
A new Morgan Stanley Research report argues that housing affordability unlikely return to pre-2022 levels as rates st...
GE Vernova's stock slide today highlights how AI data center growth and sector volatility interact with broader marke...
The FHFA proposes an outcome-based Duty to Serve overhaul to push Fannie Mae and Freddie Mac toward stronger support ...
Investors and economists are linking AI skepticism to job security and wage growth, not just beliefs about technology...
A hawkish signal from a former Fed leader could shift how investors price inflation. This deep dive explains what kev...
David Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Two popular energy plays diverge in method and risk: broad oil and gas exposure versus infrastructure income. Learn h...
Cisco is deploying personalized AI agents to its 90,000 employees this fiscal year, promising faster decisions and sm...
The S&P 500 just delivered its just best quarter since 2020, sparking questions about the path ahead. This article br...
A year after the OBBBA package, the impact on budgets and balance sheets is mixed. Here's a data-driven read on who g...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...